Suzuki Y. Hypothesis on the Etiology of Skin Complications in Japanese Patients Using Sodium-Glucose Cotransporter 2 Inhibitors .   J Clin Med Res. 2017 Mar; 9 (3): 229-230. doi: 10.14740 / jocmr2897w. Epub 2017 Jan 25. No abstract available

Sano M, Takei M, Shiraishi Y, Suzuki Y. Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys. Clin Med Res. 2016 Dec; 8 (12): 844-847. Epub 2016 Oct. 26. Review.

Sano M, Meguro S, Kawai T, Suzuki Y. Increased grip strength with sodium-glucose cotransporter 2. J Diabetes. 2016 Sep; 8 (5): 736-7. Doi: 10.1111 / 1753-0407.12402. Epub 2016 Jun 14. No abstract available.

Meguro S, Kawai T, Matsuhashi T, Sano M, Fukuda K, Itoh H, Suzuki Y. Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis. Int J Endocrinol. 2014; 2014: 927317. Doi: 10.1155 / 2014/927317. Epub 2014 Mar 11.

Matsuhashi T, Sano M, Fukuda K, Kohsaka S, Suzuki Y. Sitagliptin counteracts seasonal fluctuation of glycemic control.World J Diabetes. 2012 Jun 15; 3 (6): 118-22. Doi: 10.4239 / wjd.v3.i6. 118.

Meguro S, Sano M, Kawai T, Matsuhashi T, Mogi S, Fukuda K, Itoh H, Suzuki Y. A new preventive strategy for hypoglycemia incorporated added food diet in patients with type 2 diabetes who received sitagliptin therapy. Endocr Res. 2012; 37 (4): 175-81. Doi: 10.3109 / 07435800.2012.662664. Epub 2012 May 23

Suzuki Y , Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract ?. FEBS Lett. 2009 Jul 7; 583 (13): 2157-9

Nakashima Y, Ohsawa I, Konishi F, Hasegawa T, Kumamoto S, Suzuki Y, Ohta S. Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice.
Neurosci Lett. 2009 Oct 30; 464 (3): 193-8.

Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, Suzuki Y , Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett. 2009 Apr 3; 453 (2): 81-5.

Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S. Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity.J Neurosci. 2008 Jun 11; 28 (24): 6239- 49.

Suzuki Y , Ando F, et al. Association of alcohol dehydrogenase 2 * 1 allele with liver damage and insulin concentration in the Japanese. J Hum Genet. 2006, 51: 31-37

Suzuki Y, Atsumi Y, Matsuoka K, et al. Mitochondrial tRNA (Leu (UUR)) mutation at position 3243 detected in patients with type 1 diabetes.
Diabetes Res Clin Pract (Ireland), Jan 2005, 67 (1) p92-4

Suzuki Y , Taniyama M, Atumi Y, et al. A case of mitochondrial diabetes associated with 3243bp tRNA (Leu (UUR)) mutation with few complications, regardless of 16-year disease duration. Diabetes Res Clin Pract 2005 May 20; pS0168- 8227

Suzuki Y , Atsumi Y, Matsuoka K, et al. Acute metabolic cataract as a first manifestation of diabetes mellitus in a 12-year-old girl. Diabetologia (Germany), Mar 2004, 47 (3) p592-3

Suzuki Y , Fujisawa M, Ando F, et al. Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae. Neurology (United States), Nov 9 2004, 63 (9) p1711-3

Suzuki Y , Taniyama M, Muramatsu T, et al. ALDH2 / ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Alcohol Clin Exp Res (United States), Aug 2004, 28 (8 Suppl Proceedings) p111S-116S

Suzuki Y, Oka Y, Taniyama M, et al. A case of type 2 diabetes with high levels of plasma and urinary C-peptide. Diabetes Res Clin Pract (Ireland), Dec 2004, 66 Suppl 1 pS125-8

Suzuki Y , Nishimaki K, Taniyama M, et al. Lipoma and opthalmoplegia in mitochondrial diabetes associated with small heteroplasmy level of 3243 tRNA (Leu (UUR)) mutation. Diabetes Res Clin Pract (Ireland), Mar 2004, 63 (3) p225 -9

(Original work in Europe; before 2003)

Suzuki Y , et al. Multiple Tumors in Mitochondrial Diabetes Associated with tRNA Leu (UUR) Mutation at Position 3264. Diabetes Care 26: 1942-1943, 2003

Suzuki Y , et al. Mitochondrial tRNALeu (UUR) Mutation at Position 3243 and Symptomatic Polyneuropathy in Type 2 Diabetes. Diabetes Care 26: 1315-1316, 2003

Suzuki Y , et al. Multiple Cranial Mononeuropathies with Acetylcholine Receptor Antibody in
Mitochondrial Diabetes, Diabetes Care 26: 1318, 2003

Suzuki Y. et al. Aldehyde dehydrogenase 2 Genotype in Type 1 diabetes mellitus Diabetes Research and Clinical Practice 60: 139-141, 2003

Suzuki Y. et al. Maternal inheritance of diabetes is associated with inactive ALDH2 genotype in diabetes with renal failure in Japanese. Diabetes Research and Clinical Practice 60: 143-145, 2003

Suzuki Y , Taniyama M, Muramatsu T, Ohta S, Atsumi Y, Matsuoka. Influence of Alcohol Intake and Aldehyde Dehydrogenase 2 Phenotype on Peripheral Neuropathy of Diabetes. Diabetes Care 26: 249, 2003

Suzuki Y , Taniyama M, Muramatsu T, Higuchi S, Ohta S, and 2 others. Diabetic Vasculopathy and Alcohol Tolerance Trait in Type 2 Diabetes. Diabetes Care 26: 246-247, 2003

Suzuki Y , Atsumi Y, Matsuoka K. Alternative site testing increases complicance of SMBG (Preliminary study of three years cohort trials.) Diabetes Research and Clinical Practice 59: 233-4, 2003

Momiyama Y, Suzuki Y, Ohtomo M, Atsumi Y, Matsuoka K, and 2 others. Cardiac Autonomic Nervous Dysfunction in Diabetic Patients With a Mitochondrial DNA Mutation. Assessment by heart rate variability. Year

Suzuki Y , Taniyama M, Shimada A, Atsumi Y, Matsuoka K, etc. Diabetes Care Vol. 25: 1097-1098, 2002 11. Suzuki Y, Tsukuda K, Taniyama M, Atsumi Y, Matsuoka K, etc. 1 person. Diabetes Care Vol. 25: pp. 407-408, 2002

Momiyama Y, Suzuki Y, Ohsuzu F, Atsumi Y, Matsuoka K, and 1 others. Left ventricular hypertrophy and diastolic dysfunction in mitochondrial diabetes. Diabetes Care Vol. 24: pp. 604-605, 2001

Wang D, Taniyama M, Suzuki Y, Katagiri T, Ban Y. Association of the mitochondrial DNA 5178A / C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Exp Clin Endocrinol Diabetes Vol. 109: pp. 361-364, 2001

Murata C, Suzuki Y, Muramatsu T, Taniyama M, Atsumi Y, and 3 others. Inactive Aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol. Alcohol Clin Exp Res Volume 24: 5S Page-11S, 2000

Momiyama Y, Suzuki Y. Ohsuzu F, Atsumi Y, Matsuoka K, and one other person. Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy.

Suzuki Y , Atsumi Y, Matsuoka K. Finger infection resulted from self-monitoring of blood glucose and a new aid for reducing risk. Diabetes Care Vol. 21: pp. 1373-1374, 1998

Tsukuda K, Suzuki Y , Kameoka K, Osawa N, Goto Y, and 4 others. Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA region.

Suzuki Y, Iizuka T, Kobayashi T, Nishikawa T; Atsumi Y; and 7 others. Diabetes mellitus associated with the 3243 mitochondrial tRNA mutation: insulin secretion and sensitivity. Metabolism Vol. 46: pp. 1019-1023, 1997

Suzuki Y, Muramatsu T, Taniyama M, Goto Y, and 5 others. No association of ALDH2 genotype in MELAS. Diabetologia Vol. 40, pp. 1241-1242, 1997

Taniyama M, Kasuga A, Suzuki Y, Ozawa Y, Handa M, and 2 others. Absence of antibodies to ICA512 / IA-2 in NIDDM patients with the mitochondrial DNA bp 3243 mutation Diabetes Care Vol. 20, pp. 905-906, 1997 Year

Suzuki Y , Taniyama M, Atsumi Y, Hosokawa K, Asahina T, and 3 others. Body type in mitochondrial diabetes. Diabetologia Volume 40: pp. 987-989, 1997

Suzuki Y, Goto Y, Taniyama M, Nonaka I, Murakami N, and 4 others. Muscle histopathology in diabetes mellitus associated with mitochondrial tRNA mutation at position 3243. Journal of Neurological Sciences 145: 49-53, 1997

Suzuki Y , Taniyama M, Muramatsu T, Atsumi Y, Hosokawa K, and 4 others. Diabetes mellitus associated with 3243 mitochondrial tRNA mutation: Clinical features and coenzyme Q10 treatment. Molec Aspects Med Volume 18: s pp. 181-188, 1997

Suzuki Y , Taniyama M, Hata T, Miyaoka H, ​​Atsumi Y, and 1 others. Sleep-wake dysrhythm in mitochondrial diabetes mellitus. Diabetes Research and Clinical Practice Volume 35: pp. 61-62, 1997

Suzuki Y , Kobayashi T, Taniyama M, Atsumi Y, Oka Y, and 3 others. Islet cell antibody in mitochondrial diabetes. Diabetes Research and Clinical Practice Volume 35: pp. 163-165, 1997

Suzuki Y , Suzuki S, Hinokio Y, Chiba M, Atsumi Y, and 4 others. Diabetes associated with a novel 3264 mitochondrial tRNA mutation. Diabetes Care Vol. 20, pp. 1138-1140, 1997

Suzuki Y, Hosokawa K, Atsumi Y, Matsuoka K. Maternal inherited diabetes is predominant in Japanese and has influence on siblings. Diabetes mellitus: New aspects of pathogenesis and treatment. Eds: T. Kaneko, KB Huh, M. Shichiri, Y. Oka, Smith Gordon, pp. 53-55, 1997

Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K, and 3 others. Mental disorders in diabetic patients with mitochondrial transfer RNA mutation at position 3243. Biol Psychiatry Vol. 42: pp. 524-526, 1997

Suzuki Y , Muramatsu T, Taniyama M, Atsumi Y, Kawaguchi R, 5 others. Association of aldehyde dehydrogenase with inheritance of NIDDM. Diabetologia Vol. 39: pp. 1115-1118, 1996

Suzuki Y, Muramatsu T, Taniyama M, Atsumi Y, Suematsu M, and 6 others. Mitochondrial aldehyde dehydrogenase in diabetes associated with mitochondrial tRNA mutation at position 3243. Diabetes Care Volume 19: pp. 1423-1425, 1996

Suzuki Y, Tsukuda K, Atsumi Y, Goto Y, Hosokawa K, and 4 others. Diabetes Care Vol. 19: pp. 1304-1305, 1996

Suzuki Y , Hata T, Miyaoka H, ​​Atsumi Y; Kadowaki H; 6 others Diabetes with the 3243 mitochondrial tRNA mutation. Characteristic neuroimaging findings. Diabetes Care Volume 19: 739 pages-743, 1996

Momiyama Y, Suzuki Y , Ohsuzu F, Atsumi Y, Matsuoka K, and 1 others. Subclinical cardiac abnormality in mitochondrial diabetes mellitus, detected by 123I-BMIPP schintigraphy. Diabetologia Vol. 39: 1412-1413, 1996

Suzuki Y, Atsumi Y, Hosokawa K, Taniyama M and 5 others. Unpleasant alcohol effect in diabetes associated with 3243 bp mitochondrial tRNA mutation. Diabetes Care Vol. 18, pp. 880-881, 1995

Suzuki Y, Taniyama M, Nakamura S, Tanaka Y, Asahina T, and 3 others. Atonic bladder in diabetes mellitus due to 3243 bp mitochondrial tRNA mutation. Diabetes Research Clinical Practice Vol. 29: pp. 147-148, 1995

Suzuki Y , Kadowaki H, Taniyama M, Kadowaki T, Katagiri H, and 6 others. Insulin edema in diabetes mellitus associated with the 3243 mitochondrial tRNA mutation; Case reports. Diabetes Research and Clinical Practice Vol. 29: pp. 137-142, 1995 Year

Suzuki Y , Motogi K, Yagihashi S, Wada R, Atsumi Y, and 1 others. Macroangiopathy in a case of diabets mellitus with mitochondrial tRNA mutation at position 3243. Diabetes Research Clinical Practice Vol. 29: pp. 69-71, 1995

Suzuki Y, Kadowaki H, Atsumi Y, Hosokawa K, Katagiri H, and 6 others. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA mutation and successful therapy with coenzyme Q10. Endocrine Journal Vol. 42: pp. 144-145, 1995

Suzuki Y , Kadowaki H, Katagiri H, Suematsu M, Atsumi Y, 5 others. Posttreatment neuropathy in diabetes subjects with mticohondrial tRNA mutation. Diabetes Care Volume 17: 777-778, 1994

Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, and 5 others. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA.

Suzuki Y. Painless blood sampling for self blood glucose measurement: Lancet Vol. 339: 816-817, 1992
(European Review)

Suzuki Y. Aldehyde dehydrogenase and diabetes mellitus. Focus on diabetic retinopathy Volume 4: 28-33, 1997 (Review)

Suzuki Y , Matsuoka K. Maternal inheritance of diabetes mellitus and diabetic neuropathy. Diabetic neuropathy: new concepts and insights. Eds. Hotta N, Greene DA, et al. Elsevier Science BV: 209 pages-211 pages, 1995